ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,024
Screening encounters
4,762
Diagnostic referrals
908
Outstanding pathways
324

Screening pathway

  1. Screening4,762Encounters
  2. Positive finding1,642Documented findings
  3. Referral908Diagnostic referrals
  4. Follow-up1,085Diagnostic visits
  5. Outcome584Resolved pathways

Stage totals use different units. Pending pathways: 324. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 1966 · EXP-1966Synthetic · Site D

Full participant history through 2026-12-22, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Triage · VIA · VIA positive
  4. · Diagnostic referral · EXP-1966-T-R
  5. · Barrier documented · Transport difficulty
  6. · Contact attempt · Reached
  7. · Diagnostic booking · Initial booking
  8. · Diagnostic visit · Attended
  9. · Diagnosis · Colposcopy · Biopsy collected
  10. · Diagnosis · Histopathology · No high-grade lesion identified
  11. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-09-28
  12. · Follow-up disposition · Resolved · EXP-1966-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

4024 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-2040 · Expanded synthetic participant 2040Site C — Rural Outreach Programme
EXP-2041 · Expanded synthetic participant 2041Site D — Community Engagement Programme
EXP-2042 · Expanded synthetic participant 2042Site A — Urban Referral Hub
EXP-2043 · Expanded synthetic participant 2043Site A — Urban Referral Hub
EXP-2044 · Expanded synthetic participant 2044Site B — Peri-Urban Access Programme
EXP-2045 · Expanded synthetic participant 2045Site A — Urban Referral Hub
EXP-2046 · Expanded synthetic participant 2046Site A — Urban Referral Hub
EXP-2047 · Expanded synthetic participant 2047Site B — Peri-Urban Access Programme
EXP-2048 · Expanded synthetic participant 2048Site D — Community Engagement Programme
EXP-2049 · Expanded synthetic participant 2049Site B — Peri-Urban Access Programme
EXP-2050 · Expanded synthetic participant 2050Site D — Community Engagement Programme
EXP-2051 · Expanded synthetic participant 2051Site B — Peri-Urban Access Programme
EXP-2052 · Expanded synthetic participant 2052Site B — Peri-Urban Access Programme
EXP-2053 · Expanded synthetic participant 2053Site B — Peri-Urban Access Programme
EXP-2054 · Expanded synthetic participant 2054Site D — Community Engagement Programme
EXP-2055 · Expanded synthetic participant 2055Site E — Resource-Constrained Navigation Programme
EXP-2056 · Expanded synthetic participant 2056Site B — Peri-Urban Access Programme
EXP-2057 · Expanded synthetic participant 2057Site C — Rural Outreach Programme
EXP-2058 · Expanded synthetic participant 2058Site D — Community Engagement Programme
EXP-2059 · Expanded synthetic participant 2059Site C — Rural Outreach Programme
EXP-2061 · Expanded synthetic participant 2061Site C — Rural Outreach Programme
EXP-2063 · Expanded synthetic participant 2063Site C — Rural Outreach Programme
EXP-2064 · Expanded synthetic participant 2064Site C — Rural Outreach Programme
EXP-2065 · Expanded synthetic participant 2065Site C — Rural Outreach Programme
EXP-2066 · Expanded synthetic participant 2066Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
1813
HPV DNA
2278
Cytology
671

Navigation activity

Barrier documented
812
Contact attempt
1334
Navigation intervention
351
Diagnostic booking
1134
Diagnostic visit
1085

Documented barriers

Contact difficulty
259
Transport difficulty
267
Appointment coordination
286

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.